Company Registered Number: 02685083 Charity Registered Number {England & Wales): 1009671 NATIONAL ECZEMA SOCIETY (A Company Llmlted by Guarantee) UNAUDITED TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 llllllllll •I48cQI08• A13
240 1
COMPANIES H¢SE
NATIONAL ECZEMA SOCIETY IA Company Llmited by Guarantee) CONTENTS Page Reference and Administrati¥• Details of th• Charity. its Truste•s and Advis•rs Trustees. Report 2-11 Statwn¢nt of Trustee5' Re5pon5ibilitie5 12 Independent Exarnlnevs Report 13-14 Con$¢lidated Statement of Financial Pxtivities 15 Cons¢lidated Balance Sheet 16-17 Charity Balancè Shggt 18-19 Consolldated Statement of Cash Flows 20 Notss to the Flnanclal Statements 21-46
NATIONAL ECZEMA SOCIETY IA Company Llmlted by Guarantee} REFERENCE AND ADMINISTRATIVE DEfAILS OF THE CHARrrY. rrs TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2021 Truste¢$ Edwa Dawes QC. Chair {resign8d 19 May 2022) Ellen WInnI. Chair Stephen Pugh, Treasurer (appointed to Chair 19 May 2022. resigned as Treasurer 19 May20221 Catherine Escott mde Johnston Hannah Kuntik (appointed 16 Marth 2022) Or Simon Lovegrove {apptynted 16 March 2022) Professor Cdia Mo55 OBE Bharat Paa (appointed 16 March 2022) James Pilayanukul lapp)inled to Treasurer 19 May 2022) Hedwig Vollers (appointed 16 March 2022) Suzanne Watson Company re9islered number 02685083 Charity reglstered numb•r 1009671 Rfjglslergd offi¢• 11 Murray Street LOn NW1 9RE Chl•f execu¥• offl¢er & Andrew PrcKI Company secretary Independent Examiner MHA Maclntyre Hudson Chartered AcCOLints 6th Floor 2 London Wall Place London EC2Y SAU Principal Bankers CAF Bank Ltd National Westminster Bank plc BardayE Bank plc Status and Goveming Document National Eczema Soaety is a dwritsble company, limited by guarantsg. It was ir0[pOrated on 6 February 1992 and gIStered as a clwnty on 10 March 1992. It is govemed by its Artides of A5soLiatiOn. Subsidiary Companies Eczema Trading Linwted Page 1
NATIONAL ECZEMA SOCIErY {A Company Limited by Guarantee TRUSTEES, REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 The trustees present their amual report tcgelhet with the finanaal statements of the Group and the Charity for Ihe year 1 January 2021 to 31 December 2021. The trustees confirm that the Annual Report and financial statements of the company wmply wilh the current statutory requirements, the requirements of the companys goveming document and the provisions of the Statement of Recommended Pradice ISORPI. ap1¢able to charities preparing their accounts in aecordance with the Financi81 Reports"ng StarKlard applicable in the UK arKI Republic of Ireland IFRS 102). Since the Charity and the Group qualifies as small under section 383. the Sirategic report required of medium and large companies under The Companies Acl 2006 (Strategic Report and Directorfs Report) Regulations 2013 is not required. Pvrpos• and alms National Eczema Society was estsl$hed in 197510 support people wih eczema and their faMleS and lo work on their behaw. We rernain dedicated to these founding principles and today we continue to help people across the UK with evideno-based information and advbce about eczema and its management. We deliver this in various ways through our website. weknnars. instnr¢tional videos. social media channels, publi01nS and nUrsUppOrted Helpline. We also provwje a cdlective votce for pe¢)ple with eczema. to infom researth and influence heallh Wicy lo improve eczema care, and raise greater awareness and understandiro of the rKI1¢)n amor¥J people affected by eczema and the WKJer public. The prevalence of eczema has increased over recent decades. arKI around one n five children arKI one in ten adults are now impacted by this lrfe-challengin9 condition in the UK. While the reasons for the increase are not fully understoc*J. il does mean Ihe charity's services are needed more than ever. Our SLrpport has been especially valuable for many dvring the Coronavns pandemic. when aecess lo healthcare was more dIulL for many. There is as yel no cure for Zema and. unless you have the ndilion. it can be hard to imagine the daity challenge ol INing with relenuess itchiThJ and inflamed. painful skin. Many heallhcare professionals have limited demialology training and timely access lo specialist dem)alology heatthcare for pe¢Jple vmh eczema can often be drffiujll. National Eczema Society aims lo provide the infomwbon and support needed for people to self-manage their eczema effectively. lo become experts in their own care. learn from the experiences of others. and provide the reassurance of knowng they are not on their own. Ensurlng our work delivers our charitable aims We review our activities each year and monitor the impact of our work lo ensure we continue lo fulfil our purpose of supporting peop affected by ec28ma. Among othèr ways, w8 assess the Society's performance and achvements through the number of peOe we have helped wilh information and advice, and the quality and consistency of the resources we provide. We consider how planned aCtiV"e$ wll ¢ontn"bute to the aims and objectives we have sel, and in doing this we have referred lo the Charty Commissw)n'$ general guidance on public benefit We have had regard to the legislative and regUtry requirements for disckssing how our charitable obiectives have provided such benefit. and wnpiied ¥1h the duty set out in section 4 of the Charities Act 2011. 2021 Activlty and achSevem•nts- dellverlThg publi¢ benefit l our charitable activities focus on supp)rting people affecled by eczema and championing their needs. and further our charrtable purposes for the publ benefit. Here we pyesenl a summary of the Society's work over the year. Page 2
NATIONAL ECZEMA SOCIETY {A Company Llmltèd by Guarants•l TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021 Impact of Coronavlrus pandemlc The Society's plans ffi 2021 reflected the oryoing impact oflhe Coronavirus pandemic and importan of effective rnOte working and serVe delNery. Once again. great credit and thanks are due to the staff team, trustees. volunteers and suppliers who worked so hard over the year to maintain the Sou'ety's services and operatK)ns in thallenging circumstarw. The Society now operates 8 hybr weking model. first introduced at the stsrt of the pandemi¢, and this will continue. Like many organisations. we moved to virtual meetings in response to the pandemic and held our second AGM. in September 2021. using the vhleoconferenctng pkttorm Zoom. Trustee Board meetings are now hybrid. wilh tth in peTSM and vith•al attentjance supported. We took the difficult dl$lOn not to organise any face-to-face events again during 2021. rellecling the ongoing challenges of Covid restrict$. The Swevs Helpline, websf(e and wcial media communications continued operating as usual throughout the year. Coronavirus also affected some of our fundraising activity. nolabty thallenge events and community fvndraising. We are graleful to our members and supporters fc being so generous with Ihesr donatK)ns durirvj the year. at a time of conlinued uncertsinty. D•llvorlng Inlomiatlon and advlc• for peopl• living with e¢zema The Society continue5 to provKle a V•ide range of high quality. evidenc&based information and advice about eczema and its managomgnt for people with the condrfion arwj thgir famil$. Our eczema Helpline is at the heart of the Society's work. enabling the charity io provide the perstThlised independent adw¢e and reassurance needed by people strugglin9 lo ¢ope with eczema vtherever they live in the UK. We receive around 1.600 lelephone, email and message enquiries a year from pants of Children with eczema and aduks living with Ihe condition. These cover o wide range of questions absyJt eczema symptoms and trealmenls. from the latest biologic drug5 to eczem3-friendly clothing. We offer a demiatology nurse call4ack service for Peop who have more ccmmplex enquiries. and around 40¥0 of Callers are helped by one of our experienced dermatdogy nurse advisers. Our Helpline is available free of tharge to anyone affected by eczema in the UK who needs our supporL Aongside our Helpline. the Soctety [OduceS a wide range of patient inf0m)atl booklets and factsheels about eczema management and treatment, available online and in print. We distribule prinled copies at events the charity Organe5 and altends. and we prowde(l over 12.000 copies of our printed publications to healthcare professh)nals ¢Juring the year. for onward distribution to patients in h05pilal demiatology dinics and other healthcare settings. National Eczema Swety fadsheets ard bcK)klets are updated regularfy on a rolling VIeW cyde and ¢he¢ked by heallhcare professKJnals to ensure the infom)ation is accurate and uptO&date. We updated and reprinted a number of publications over the year. including our Itching and Scratching bc¥)klet. Paste Bandages anil Wet Wraps b¢klet and ChildhoctyJ Atoptc Eczema gukye. We continue to raise awarenes5 of local volunleer4ed pat*nt Sup1 groups. ty providing information and a presence for these groups on the Society's websrte. Unfortunately. because of ongoing Covid restridions, the infomiation tslk planned by the sOcty.$ Wesl Surrey and North-East Hampshire Support Group had to be postponed again. where Dr George Monuieff was due to speak about the causes ol eczema arKI latest thinkiThJ on eczema eare. Page 3
NATIONAL ECZEPIA SOCIETY (A Company Limited by Guarantee) TRUSTEES. REPORT (CONTINUED} FOR THE YEAR ENDED 31 DECEMBER 2021 We publish all our eczema Informati on the Society's website, whh received over 1.3 million visits during the year. antj we promote health advice messages through ijur sock41 media charbnels. media engagement and other extemal communications. This year we launthed 8 series of popular webinars for people affecled by eczema and their families, on various eczema management topbcs, and ordings olthese are available lo view (M) the Society's Y¢)uTub8 pagg. NES m•mb•rshlp sch•me National Eczema SOcty is a membership organisation and we are very grateful lo our 2,300 members who 5UPPOrt the Society through their annual membeF5hip fee and addilN)nal donations. Members receive our quarterly magazine Exchange. which features exp¢rt information and news about eczema. Mambers are also encouraged to attend Ihe &xiety's Annual General Me8ting and contribute their ideas on the running of the charity. As in previous years. support for our tharity extends far beyond our membership and we remain grateful to all our domrs. and to those members who continue lo support us financially even though they no h)n9er have any Perso need of our help. Representing patient views As a national patient organisalion for people eczema. Ihe &xiety plays a leading role in providing collective voice to champion the needs of those affeded ty the condition. We seek lo improve health outeomes for people th eczema by influencing health policy and participating in groups like the All Party Parliamentary Group Skin (APPGS) and working with professional bodies like the British Association of Dermatologists. As a mber of Ihe steering group. we contrsbuled lo the major NHS England Dermatology Outpatient Transfomwtion Programme. which developed a range of new guidanee lo help dermatology heahhcare providers meet the challenges of responding to the disruption to servi¢es ¢aused by Covid_ This covered are85 like leledem)atology and wailing lists. We also worked to raise awareness of the need for better understanding and representation in dermatolo9y for people with skin of colour. Reflecting the growng patient interest and awareness of the effects of topral steroid medication, and concerns abcwJl t¢)pul steroid withdrawal. the Socyety worked with the British Association of Dermatologists to develop a Po11)n statement on topical 51eroid withdrawal. Among other things, in the ststemenl we sought to darify the various terms LFsed to describe topical stgfoid wthdrawal and the different reactkjns peOe mwJht experience when stopping using topical steroid Ireatrnents. Topical steroid withdrawal is complex and research into the causes, symptoms and treatsnents is limited. Nattonal Ec2ema Soo'ety wants to see more searCh in this area. One of the challenges is that the symptoms people experience when stopping using twcal slerohds can appear similar lo those of poorly controlled eczema. These symptorrts can be very painfvl and distressing. The Society is emphasising the importance of using lopical steroid treatments safely and effectively, and among other things is calling for clearer labelling of topical sleroKls to show lhe polerrylstrervJth. We continued lo grow our organisaknon81 eaparjty lo supw)rt patient invofvement in shaping research. NES is approached regularty by researchers seeking patient views and lo leam from patient experiences. It is so encouraging to see such a range of research underway and new treatments in the pipeline, following a IcM)g peri1 when e¢2ema was largely overlooked. The Society is actively supporting eczema research by participating in study steering groups. providing patient perspectives for research tlla15, and working with universities and companies that a assessing and devebping new drug treatments. We do this to help ensure eczema researth has the greatest chance of suc(*ss in finding new treatrnents and ultimatety a cure. Page 4
NATIONAL ECZEMA SOCIETY IA Company Limited by Guarantee) TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021 We also provide a patient perspective lo dinical 9uideline devek)pment. Ihe assessment of new treatrnents. and policy wnsullati¢)ns. We contributed to the assessment by the National Institute of Health and Care Excellence (NICE) and the Scottish Medicines consorbum ISMCI of a new eczema drug Car baricitinib. which was apwoved for use by the NHS in 2021. This inlended for aduts with moderate to Seve eczema. Bariciknnib is a type of drug known as a Janus kinase IJAKI inhibitor and it wort¢s in a drfferent vrdy lo other immunosuppressant and b91¢ drugs ¢urrenUy used to treat eczema. As eczema affects people in different ways. it 15 important that we have a range of treatment options to help ensure people c8n awss a treatrnent that works effectivety for them. During the year, we contributed a patient persWe and evidence io olher NICE and SMC vIews, induding assessment of several other new drugs for eczema. induding a new ts'obgic treatment called tralokinumab and hyo JAK-inhititcf drugs ialled upadacitsnib and abrocifinib. 11 is disappointing that efforts to press NHS England and NHS Irrprovemenl to darify their prescribing guidance on om(Jlients for people with eczema has not yet been fulty realised. The current guidance Is confusing and does not make it suffi¢ienUy clear Ihat GPS can - and should - tXeslbe leave-on emollients for people wrth lonlem inllammatory condibons. including eczema. We wll continue working with other dermatology organisations. led by the Dermatology Council of England and British Association of Demialologists, lo press forthe agreed "¢a.0n guidance to Oe issued lo prescribers and commis5)ner5. In olher inlluencing aclivity. thè Soci8ty continues to work with the Medipnes and Healthcare Products Regulatory Agency IMHRAI to suppori the Agency's communution Programme to raise awareness of ffire risks of emollients. Emollnt pa<a9ing now comes with ffi waming labels. Emollients are not fiammable in themselves. or when Ihey are on the skin. Hcrwever. if bedding, ¢bthing or dressings containing dried emollient resKJue catches fre <fr(n a naked fiame). they bum more ¢wlckly and intensely. In O¢lober, the S¢xiety awarded a £10.000 grant for an important new research study, to Inveslwjate the impact of sleep disturbance on children wth eczema and Iheir families. It is the first time the charity has directly fvnded eczema research for some years and we are considering knnding more studies in fLrture. Many children experience disturfoed sleep. especially vthen eczema is severe. Sleep disturbance causes .dness, which in lum affects chikjren's ability to concentrate, their mcod and general well- being. The impact on paren15 cariryJ for th[1dn with e¢zema be profound too. The project 15 being led by Dr Connor Broderick and Professor Carsterb Flohr. from Sl John'5 Insbtute of Demiatology at Guys and St Thomas, Hospital in Lmocm. working with colleagues at other universits.es and hospitals in the UK. The Society has collatxyated with Ihe UK DermatolcJy Clinical Trials Netsvcffk to award this research granl. Awareness rnlslng. communications and ¢ampalgnlng The charity undertakes a Tange of acljvities lo raise awareness and underSling of eczema amoNJ tha geneial public, and to promote the infomiation and adce the Society provides living with eczema and their families. The theme for National Eczema Week in September was'my Eczema Story., when we called on people living with eczema lo share their experiences of living with the cwlilion. Eczema is different for every person who lives with this debilitating long-tefm conditson. Through sharing experiences, ideas and top tips, we sought lo help others feel they are not alone. The phySal symptoms of eczema can be extremely dIU, including the rèlentless itchirvJ and having lo cope with raw, inflamed and bleeding $kin. The hidden cost of eczema is the profound impacl it can have on people's emotional well-being. Paye S
NATIONAL ECZEMA SOCIETY (A Company Llmlted by Guarant) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021 To support the campaign we produced a series of very personal. emottve and practical short videos of National Eczema Society members and eczema advocates, which we promoted ac¥oss our social mèdia channels. We are very gratefvl to everyone took part. and Speal thanks are due to radio DJ Y8sm¥i Evans for $upWr@ the campaign Aongside the campaign. we ntroduced a range of new rforniation resources lo help people manage eczema as effectively as possible. These 'My Eczema Tcdktr resovrces offer practical advice to supwt people with the many psychokjgical and emtional challenges of INing with eczema described so vividly by those sharing their eczema stw during the campaign. We achieved excellent camp8ign Verage. induding several prominent articles on the BBC website. and stories ift many regional and some national rWSpapers. Engagement on social media was excellent too. We are especialfy grateful to our courageous patient advocate Kymmene Dawson, 4vho once again shared her challenging experiences of eczema in the medÈa. The Society contributed lo the media launch of Eli Lilly's #GOALS eczema management inib"ative and chief executive Andrew Proctc took part in several radio interviews related to this initiative during National Eczema Week. We continued lo grow our SLKial me(Jia reath and aCtsty during th6 year. reflecting how pèople increasingly seek and share infom)alK>n atK)ul eczema. The Society now has over 22,000 followers on Facebook. an increase of over 2C($0 over the year, and we grew our following on Twitter to over 8,000. We more than doubled the number of Instagram followers over the year. lo reach 7,700 by the end of 2021. Capacity constraints and Compe"ng priorrties continued to impact on the media work we are able lo undertak8. The Souety provided press comment on a number of eczema stories in the media over the year. and we again focussed our medra engagement arwnd National Eczema Week. Growing income and building financial sustainablllty In 2021. we continued to focus income generatp)n to enswe we have the reSoUS to athieve our Charitab objectives and build future financial svstsinability. We are immensely grateful to our thoughtful and generous supporters who choose to leave a 9ift to National Eczema &Kiety in their Will. Ouf income from legacie5 in 2021 was once again higher than in some previous years. and this has been so inwtant in tlIdIng a stronger financial footing for the Society during a pefiod of uncertainty. We continue to develop partnerships with ¢ompanie5 that Share our values and are willing lo support ourwork and engage in joint education and awareness-raising actiwty. During the year Abbwie. Eli Lilly. Johnson & Johnson, LEO Phama. Sanofi and Thomton & Ross were all corporate members. There werè many fundraising highlights durirKJ the year and also chaInge$ as a resull of the impact of Covid. We were pleased to see the return of the London Marathon. stsged in Oclober, and we are grateful lo NES runner5 Joe Jor5 and Oexy-Lea Palmer for taking on the race and raising much- needed funds for the Socw. The Society's West Surrey and NEast Hampshire Supwt Group was able lo undertake local fundraising activty again. following the relaxats.on of Covid restriclions, and presentgj a cheque for £2.000 al ihe Annual General IAeeb"ng in September. Th8 Society's members and donors generou51y supported Ouf summer and Christmas fundraising appea15 once again and we are gratefvl lo everyone who supported the Society in drfferenl ways with 1r donations over what has been anolher challenging year with Covid. Pa9e 6
NATIONAL ECZEMA SOCIETY (A C¢mpany Llmlted by Guaranlee) TRUSTEES. REPORT {CONTINUEO) FOR THE YEAR ENDED 31 DECEMBER 2021 Organisational developmenl During the year. we revieb¥ed our understanding and or9anisattonal approach to equality, diversty and ¥)clusion. and are working towards better representing and servirrfJ all communTtie5 of people who are affected by eczema. We have a parbcular fows on recruitment. and we proactively encourage people to apply for slaff and volunteer roles who Contri different perspeclives and INed experience. We successfully completed a maior project to update our spter database 50fiware. which 8150 saw us move lo a more secure ch)u&based hosting solution. We built our $tsff team and leadership capacAty with Ihe app)intrnenl in December of Samantha Skelding as Deputy Chief Exeujtive. Trustees agreed new vision and mission ststements for the drity. which are: Vision.. Our visw is a wortd tree of eczema. Mission.. We make life better for people eczema and their families. We do this by providing the informatr)n, advi and emotional support needed to manage eczema well. We also create a healthier future by raising awareness and understanding of eczema. campaigning for improvements in care. and supporkn.ng resgarch inlo new treatrnenls and prevention. 2022 Plans and d•v•lopm•nl priori¢ie$ Lwking ahead. we aim to ensure National Eczema Socrety ¢ontinu8S to achi8va th8 greal8sl wnpa we can for members and others living with eczema. The charity's core charilable work will continue. as well as taking forward stralegically important acbvty indudrng buildirrtJ our db9ital capability. our fundraising. supportirrfJ research and strerythening our work to iffr$)¥e eczema care. Oevelopment priorities ft)r 2022 indude.. Dellver Infonnatlon and advlce DeveloFxng arKI launching an online fiwum rffi the sety's website to pn)vide peer support for people affected by eczema. Scope and introduce a WhatsApp dwnnel arKI an instsnl messaging oplion on the Society's wgbsile for advice enquiries. Work in partnèrship with St J(thn's Defflhkndemy to co-produrA and deliver eczerna information webinars. Pallent voice Contribute patient perspectives to dinical guideline devebpment and Ihe assessment of new treatments and policy consumalions. working with regulatory bodies induding the MHRA, NICE and the SMC. Continue to be a campaigning voice for people with eczema, to ChaInge iwualit*s in health policy and practice. Page 7
NATIONAL ECZEMA SOCIETY {A Company Limited by Guarantee) TRUSTEES. REPORT ICONnNUED} FOR THE YEAR ENDED 31 DECEMBER 2021 Communications and aw¥ene$s ralslng Lead the annual nalional flagship awareness event. National Eczema Week in September. Research and patient involvement Grow our organiWk)nal capacty to suptth patient and public involverr*nt in shaping eczema researth. Ory•nisation and governance Strengthen our and approath to equality. thversty and inclusion. Flnancial Results We planned for a budget surpkjs in 2021. Consistent with strategic intention to athieve a balanced OT surplus budget on an onwing basis. We have actually achieved a more wbstantial surplus than budgeted. largely as a result of better than expected income from aCY gifts. The outcome for the year was a sUu$ of £185.322. This ¢paS wtlh a surF4us of £186,521 in the year ended 31 De¢ember 2020. At 31 December 2021. our ServeS had increased to £721.691 (£536,369 at 31 December 20201. We woultl like to thank the many people who. as in prevK)us years, by joining or newing their membership, supporting cyjr appeals and fundratsing in a variety of often innovative ways. have enabled us to cfy)linue our work. The efftwts 8nd contribution of supprS and volunteers i8 invaluable lo the Society. We are gratefvl also to those who remembered the Society in their Wills. the charitable trusts and companies that have supported u5 during the year. and to all the healthcare professionals who have provided vs $0 mu¢h time. advt¢e and supwrt espeoalty MberS of the Medical Advisory Re$¢r¥es Policy The Irustees aim lo maintain free re5erve5 in unrestricted funds at a level which equates to approximately six months unrestricted charilable expenditure. The truslees consider thal this level will provide sufficient funds lo respond to unforeseen loss of inci>me and give Ihe charity time to build alternative sources of income. restructu aclmb.es or close or meffJe the charty. The trustee5 have reviewed the Reserves Policy in 2022 to ensure it remains appropriate and Sufficient given the nature of the Society's InMe and historical trends. and have determined that It is often appropriat8 to hold a larger reSee as lega¢y income in particular Can be sKJnificant in size and unprgdictable in timing, and il does nol match the more even fiow of the Sooety's expenditure. The tsaran held in unre5tn.cted lunds at 31 December 2021 was £719,953 of wlych £699,114 is regarded as free reserves. after alh)wing tr funds lied up in tsngible assets and those funds allocaled for Specif purposes. As bud9eted six-month expenditure overJanuary-June 2022 totsls approximately £241.300. Current reserves are now well ahead of the anKxJnt required in Ihe Reserves Policy. Noting this surplus and nomial sustainable levels of expenditure. the trustees intend to despnate amounts beyond those needed lo mainLiin the agreed minimum reserve. for the purp05e5 of researth. A parb'cularfo¢us of our searCh interest will be the poorly understOCMJ issue of topical steroKI wilhdrawal. Page 8
NATIONAL ECZEMA SOCIETY IA Company Llmlted by Guarantee) TRUSTEES, REPORT ICONTINUEDI FOR THE YEAR ENDEO 31 DECEMBER 2021 Risk Management The trustees have taken steps to identify and address major risks faoNJ the Society. including maintaining a risk register. The principal uncertainty in respect to the SocieV5 future is the ability to maintain suffi(aenl income lo deliver the charity's servtts. and ensure the Society has adequate resour¢es to cornply wth regulatory changes affecting the voluntary sector. Greater focus and investment are being tlirected to fvndTrrgng aclivilies. to ensure the &Kietygerrales sufficienl income each year to fund planned activities. The principal risk of finla1 sustainability for Ihe charity is dosely InItored by the trustees on a regular basis. induding reviewing management accounts at quarterly Board meetings. Attention also continues to fo¢us on rK>n-financial risks induding heamh and safety. pti1)n. security. confidentiality and data protection. which a supw)rted by appropriate pICieS and procedures as well as managemenl updates as needed. Investffl8nt Policy AJI surplu5 funds we currenlly placed M depos The Trustse$ and Organlsatlon The Society is a charitsble company. AlthrMJgh cald trustees. we are the directors of the company for the purposes of¢ompany law. The trustees who served during the year up to the date ofthis report are given on page 1. The Society's govemance wocesses are set out in its ArtKles of Assouation. The 8oar(l of Trustees administers the Society, which mee15 routinely frNJr times a year and additionally as circumstsnces demand. A chief executive is appointed by the tnFstees to manage the day-to-day operations of the Society wilhin a framework agreed by the Boafd. There must be a minimum of tree trustees Lwt there is rn) maximum nurthr. and tfuslees must be elected by the members ofthe Souety at its Annual General Meeting {AGM). Trustee5 may be co-opted onlo the Board during the year and must th stsnd for eWion by the members at the next AGM. At leasta third of trustees are required lo retire from offi¢¢ each year butmay. rfthey wish. offerthemselves for rdeCI10n al the AGM. Trustees are ¢ruited thr¢Jugh the Society's rnembewship, Irxal support groups, other eczema community nefv40rks and open advertising. In seeking truslees. the Society has re9ard of the need to ensure that the Trustee Board has an appropriate range of professional skills and experiere, reflects wr commilment to diversity. arKI dso that trustees are drawn from different areas of the UK. Ajthough not e¢Jnstituttonalty binding, the Society wishes to work towards alKJning with the Charity Governance Code. which recommends tnJste8s serve fixed tem)s in office. The guidance re¢omm8nds Iruslees serve an initial three•year term. wth the possibility of being reolected by mernbers for a further Ihree-year period. Trustees in particular rde5 {e.g. Chair. Treasurer) c(yJd serve a longer nine-yeai pefiod, subject to forn1 review. New trustees are Fwvided wlh an 1ntrryJudn padt. TthKh indJe$ the Soryety's governing documents. copies of the past yearfs accounts. and a briefing on their duties and responsibilities and of the Society's govemance pr¢xesses. Ptior to joining Ihe Board. new trustees wll usually attend al least one Board meeting in an observer capaiity. which gr¥es Ihem the opportunty to meet the trustees and chief executive. Page 9
NATIONAL ECZEMA SOCIETY (A Company Limited by Guaranteè) TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021 Ouring the year. the decision vras taken to recruit several new trustees with the aim of refreshing and enhancing the collective professional skills 01 the Board. and strengthening the diversity of our goveTnance. The trustè8 OPPOrtuntty was promoted to the S(xi&ty meMrship. other supporters and wÉder eczema community. We opted lor an open. competitive recruitment process. Following shortlisting arKI inler¥iew by a sub-committee of trustees. it was decided to apwnl four candidales as new trustees. namely Hannah Kunzlik. Dr Simon Lovegrove, Bharal Pandya and Hthig Vollers. All four appointees attended the March 2022 Board meeting as observws, afterwhth theywere confimied in posL Trustees receive no remunerati trustee has a benthal interest in any of the group companies. In June 2021. the Socw estsblished a Medtcal Advisory Board {MAB) comprise(l of he8lthcare professionals who act in an advisory and ambassadorial capacity for the charity. Members volunteer their tsme and are all experience¢J heatthca professtonals who work in the fieK1 of demalology, and Vrt have a particular professional interest in eczema management and research. The MAB is chaired by Nalh)nal Eczema Society Trustee. Professor Celia Mos5 OBE. The trustees set the remuneralK)n of the thief execulive and approve the remuneration ofolher Soci8ty Staff. Remuneration levels are based on research of similar rdes and bgn¢hmark salary data. Trustees took the decisK)n to devregisler wth the Office of the Scottish Charity Regulator IOSCR} and the process was completed in O¢lober 2022. It is not a ulatOry requirement fo¥ National Eczema Society lo be registered in Scotland arKI de-registering helps reduce the Society's administrative and operating costs. Alhough no longer registered OSCR. NalN)nal Eczema Soaety continues to provide advice and support for the benefft of everyone affected by eczema in the UK. C¢)vid statement and response National Eczema Srtiety has been able to maintain its core se$ arKI othèr charitable activilies during the Coronavirus pandemic period las of June 2022). most of which are delivered remotely including our valued Eczema Helpline service. This has required thange5 in the way the eharily operates, with staff now routinely working remotely at home. We have invested in our IT and cloud computing capability to support remote working and now have an effective hybrid working model. Vve have been caub'ous with plannin9 to re4nlrThluce face-lo-face events. and have taken the decision not to organise such events again wi 2022. The Soriety benefts from a diverse range of income swr¢es and therefore more resilient to significant unexpected events like Covid. Rising infiats.on in 2022 will present challenges. in both managing costs and achieving income targets. Legacies are a signfficant element of the Society's overall income mix. and we expect legacy income to be tower in 2022 than previous years. although this is faclored into our planning. Members. other individual donors and corporate partners have continued their support during the pandemic. We expect some trallitional income sources lo be stronger in 2022, including income fr¢)m Challenge events and we have faclored this into our budgeting. Hence, while remaining vKJilanl to Ihe ¢hangeable extemal environmenL the trustees do not have reason to be concerned over the continued financial sustsinability of the charty from the immediate and longer-lerrn economic impact of Covid. As referenced eadier, the tru51ees are rewewng the Reserves Policy in 2022 lo ensure it continLFes to meet current and kn¢)wn future requIrnents. Page 10
NATIONAL ECZEMA SOCIETY {A Company Llmlted by Guaranlee) TRUSTEES. REPORT (CONTINUED} FOR THE YEAR ENDED 31 DECEMBER 2021 Th& Tnjslges ReFort has b8en w8paTed in acC((lanCe with Ihe provisions appli¢ablg lo entilies subject to the small companies rogime. This report was approved by Ihe Board of Trustees on 8 August 2022 and signed on their behalf by: Stephen Pugh Chair Page11
NATIONAL ECZEMA SOCIETY {A Company Llmlted by Guarantee) STATEMENT OF TRUSTEES. RESPONSIBILMES FOR THE YEAR ENDED 31 DECEMBER 2021 The Trustees (who are also the dI¢t5 of the Charity for the purposes of company law) are responsible for preparing the Trustees. Rep(Kt and the financial statements in accordance with applicable law and United lfjngdom Attounting Standards (United Generally AcCted ACting Practice}. Company law requires the Trustees to wepare financial slatemnts fty each finarKial year. Under company law. the Trusle8s must not approv8 Ihe financial statements unless they are sa115fied that they give a true and fair view of the state of affairs of the Group aThJ the Charity and of their incoming resources and application of resryjrces. including their income arnl expendilure. for ttiat peric*J. In preparing these financial slalements, the Trustees are required to". select suilable a¢counting polioes and then apply them consislenuy. observe the methods and prinoples of the Charities SORP (FRS 1021.. make judgements and accountiThJ estimates that are reasonabbe and prudent: state whether applicable UK Accounting Standards {FRS 1021 have been followed. subj'ect to any matsrial departures disclosed and explained in the finanaal stalernents,. prepare the financAal statements on the going ¢M basis unless it is ¥)appropriate to presume Ihat the Group will continue in business. The Trustees are responsible for keeping adequate accounb'rrfj reoJrd5 that are 5uffi(xent to show and explain the Group and the Charivs transactions and disdose with reasonabk aerjjraey al any time the financial position of the Group and the Charity and enable them lo ensure that the financkal statements comply with the CoMpanS Act 2006. They are also responsible for safeguarding the assets of the GTOUP and the Charity and hence for taking reaSonae steps for the prevention and detection of fraud and other irregularities. Approved by order ofthe Merrthrs ofthe Board ofTrustees and signed on its behaff by.. Steph•n Pugh Chair Date.. 0810812022 Pa9e 12
NATIONAL ECZEMA SOCIE {A Company Llmlt•d by Guarantsel INDEPENDENT LXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 Independ•nt Examin•rfs R•port to th• Twsl•es of National Eczerna Society Cthe Group'l I report lo the Chanty Tru51ees on my examination of the consolidated accounts of the Group. sel out on pages 15 to 47. comprising Ihe Nationd Eczema Society (Yhe parent Chantl) and ¢ts subsidiary undertakings for the yEar ended 31 December 2021. Responsibilities and Ba515 of Report As the Trustees of the parent Charity {arKI its Director5 for Ihe purposes ol rnpanY law) you are TesFKJnsible for the preparation ol Ihe consolidated accounts of the Group in acCOrdar with the requirements of the Companies Acl 21))6 Ilhe 2006 Ad). Having satisfied mysdf that the consdidated actounts not wuired to be auditetl under Part 16 of the 2006 Act and 8re eligie for independent examinat. l in respecl of my examination of the Group's accounts as carried out under section 145 of the Charities Acl 2011 (e 2011 AcV}. In ¢aNwng out my examination I have followed the Direction5 given by the Chanty Commission Under section 145151{b) of the 2011 Act. Ind•ptnd•nt Examlnerfs Staternent Since the Group's gross income exceeded £250.CN)O yr MIr must bè a member of a body listed in section 145 of the 2011 Act. I confimi that l am qualrfied lo undertake the examination because l am a member of the Institute of Chartered Accountsnts in EnglarKI aThJ Wales. wthich is one of the listed bodies. I have completed my examination. I confim that rn) matters have come lo my attenti in connection wllh the examination giving me cause to beIVe in any material respect.. accounting records were not kept SpeCt ot the parent Charity and its sS1dlaneS as roquirod by section 386 of the 2006 Ad,. or the accounts do Ml accord th those rets)rds: or the accounts do not comply V+ith the accounting reqU1ments ol section 3% of the 26 Act other than any requirement that the accounts give a In and f&"rf view which ts not a matter n$ered as part of an independent examination- or the accounts have not been PrePad in acrdanCe the methods and principles of the Statement of Recommended Practice for aCUn.ng and repcwting by charilies applicable to Charities preparing their accounts In accordanc with the Financial Rewrting sta[d ap1¢able in Ihe UK and Republic of Ireland (FRS 102). I have no concerns and have come across no other matters in conneclion with the examination lo which attention should be drawn in this report in order to enae a proper understanding of the accounts to be reached. Page 13
NATIONAL ECZEMA SOCIE IA Company Umlled by Guarantee) INDEPENDENT EXAMINER'S REPORT {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021 Signed.. Dated: 151W2022 Stuart M¢Kay 8S¢ FCA DChA MHA Ma¢lntyre Hudson Chartered AcUntsnts London. United Kingjom Pa98 14
NATIONAL ECZEMA SOCIETY (A Company Umltsd by Guarantee) CONSOLIDATED STATEMENT OF FINANcL AcnvmES {INCORPORATING INCOME AND EXPENDITURE ACCOUNTI FOR THE YEAR ENDED 31 DECEMBER 2021 Unrestricted funds 2021 Restrlcted funds 2021 Total lund$ 2021 Total fvnds 2020 Incorne from: Donations and lega¢ies other trading activities". Income Irom fvndraising Income from trading activibes Investments 528.134 528.134 545.887 4.921 1.801 4.921 1.801 856 1.321 1,809 2,143 Total Income Expendlturè on: Raising funds: Fundraising costs Trathng costs Other raising fvnds Charitable activities 535.712. 535.712 551.160 12.828 12.828 54,690 15 19.976 340,975 19,976 351,725 10.750 308.813 Total expendllure 373.779 10.750 384,529 363.518 Net movement in fund5 before other re¢ognls*d gain$ Other recognised gainsl(losses): Gainslllossesl on pension sdme 161.933 110.750) 151.183 187,642 19 34.139 34,139 {1.1211 Net movement in funds 196.072 {10.750) 185,322 186.521 Reconclllatlon of lunds: Total lunds brought foryrd Net movement in funds 523.881 196.072 12.488 {10.750) 536.369 185,322 349,848 186.521 Total fund5 ¢arried foThYard 719.953 1.738 721.691 536.369 The Ccffisolidated Stalement of Finanoal Activitses indudes all gains and SseS recognised in the year. All income and expenditure derive from continuirb3 acbwbe$. The notes on pages 21 to 46 part of tsse finanual ststemenls. Page 15
NATIONAL ECZEMA SOCIETY IA Company Llmlted by Guarants¢l REGISTERED NUMBER: 02685083 CONSOUDATED BALANCE SHEET AS AT 31 DECEMBER 2021 2021 2021 2020 2020 Note Flxed assets Intangible assets Tangible assets 14 8.832 27.886 15.828 38.052 15 36.718 53,880 Curr8nt assets Dgbtors.. Ar)Unts fallin9 due 1n year Cash at bank aTrJ in h8rn1 17 159,515 649.260 .598 597,755 808,775 688.353 Creditots.. Amounts falling due Vithin one 18 1115,028 (156,Ci11 > Net Currenl assets 693,747 532.352 Total assets less current Ilabllltl•s 730,465 586.232 Creditors.. Amounts falliThJ due aftor than g year 19 18,774) {49,863) Total net awts 721,691 536.369 Group funds Restricted funds Unrestricted funds 20 20 1.738 719.953 12,488 523,881 Total funds 721.691 536.369 The Charity was enliued to exemption from audit under seclion 477 of Ihe Companies Act 2006. The Members have not required the company to obtain an audit for the year irb question in accordance with section 476 of Companies Act 201%. The Tfuslees ac&nOed9e their resporksibilities for complwng vith the requirements of the Companies Act 2006 with respect to accounting recwds and preparation of finanaal statements. The financial statements have been prepared in accordance with thè provistons applicabb to entibe5 subject to the small companies regime. Page 16
NATIONAL ECZEMA SOCIETY IA Company Llmlted by Guarantee) REGISTERED NUMBER: 02685083 CONSOLIDATED BALANCE SHE ICONTINUED) AS AT 31 DECEP418ER 2021 The financial ststemenls were approved aTrJ ajthorised for issue by the Truslees and ggnetl their behalf by.. stophon Pugh Chair Date.. 8 August 2022 The notes on pages 21 to 46 forni part of these finela1 slatsments. Page 17
NATIONAL ECZEMA SOCIETY IA Company Limited by Guarantsel REGISTERED NUMBER: 02685083 CHARITY BALANCE SHEET AS AT 31 DECEMBER 2021 2021 2021 2020 2020 Note Flxed assets Inlangible assets Tangible assets Investments 14 8.832 27.886 11)0 15,828 38,052 100 15 16 36.818 53,980 Current assets Debtors: ArUnts fallirvj due one ye Cash al bank antj in hand 17 211.072 624.435 136.435 577.251 835,507 713,686 Credhors.. Amounts falling due *ryihin one year 18 (113.2281 (156,001) Net current assets 721279 557.685 Total assets less current liabilities 759.097 611.66S Creditors.. All1nts falling due after rrwye than one year 19 18.774) 149.863} Not a$sets excludlng pen$lon asset 750.323 561,802 Total net ¥$sets 750.323 561,802 Charity fvnds Restricted funds Unrestricted fijnds 1.738 748.585 10.753 551,049 Total funds 750.323 561,802 The Charitys net rnovement in frJnd5 for the year was £188,52112020- £189,727). The Charity was entitled to exemption from audit under secth)n 477 of the Companies Act 2¢JO6. The Members have not required the company to obtain an audit fLY the ar in question in acoydance with section 476 of Companies Act 2006. The Trustees acknovledge their responsibilitS for complying wth the requirements of thg Companies Act 2C(J6 with spect to aco)unting reccwds aThJ prgparation of finanaal statements. Page 18
NATIONAL ECZEMA SOCIETY IA Company Limited by Guarantee) REGISTERED NUMBER: 02685083 CHARITY BALANCE SHEET ICONTINUEDI AS AT 31 DECEMBER 2021 The financial ststements have been prepared in accordance Wth ts provisions applicable to entiti.es subject lo the small companies regime. The financial statements were approved and aulhorised for issue by the Truslees and si9ned on their behalf by: Stephen Pugh Chair Dat8.. 8 August 2022 The notes on pages 2110 46 form wt ofthese finarKial ststements. Page 19
NATIONAL ECZEMA SOCIETY {A Company Llmlted by Guarantee) CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2021 2021 2020 Cash Ilows froffl op8Taling aclivities Net cash used in op8rakn.ng lI¥1th9$ 22 52.795 180,039 Cash Il¢)ws from Inve$tlng a¢tlvltl•$ Inv8strngnl IrMe Purchase of inlangible assets Purchase of langible fixed assets 856 2,143 {7,9201 (15,4381 15 (2.146} Net cash used in investing act•¥ities (1.290 {21.2151 Change in rAsh and cash •quival•nts in th• year 51,505 158.824 Cash and cash eqUiVentS at the beginr4ng of the year 597.755 438.931 Cash and ¢ash equivalents at the end of the year 23 649.260 597.755 The notes on pages 21 to 46 fomi pwt of these ffinantial statements. Page 20
NATIONAL ECZEMA SOCIEtY IA Company Lknitsd by Guarant••} NOTES TO THE FIN4ClAL STATEMEPffiS FOR THE YEAR ENDED 31 DECEMBER 2021 G•n•ral Infomiation Nalional Eczema ScKiety is a charitsble Company limited by guarantee and is registered 7Mth the Registrar of Companies {Company Registered Number: 02685083). the Charity Commission in England and Wales (Charity Registered Number. 19671). The Charity deregistered from the Office of the Scottish Charity Regulator {OSCRI on 15th October 2021. In the event of the Charity being wcwmd up. Ihe liability in respect of the guaranlee is Itmited to £1 per Member ofthe Charity. The address of the registered office is given in Ihe Charity infomabon on pa9e 1 of these financial Stslements. The nature of the Chaiitys operatrons and winc4pal activitie5 we detsiled in the Trustees. ReporL The significant ae¢Cn.ftg poli$ applied in tt)e preparation of these finala1 5tstements are sel out below. These policies have been c4Jnsistenlly applied to all years wesented unless otherwise staled. A¢¢ounting policies 2.1 Basis of prnparation of finan¢ial statsm•nts The financial stslements have been pPared in acoy)rdance with the Charities SORP (FRS 102) - AcLX)unling and Reportng by Charities.. Stsiement of Recommendeij Practice applicable to charities preparing their accounts in a¢¢ance with the Finanual Reportin9 Standard applicable in the UK and RepublK of Ireland (FRS 102) and the Companies Ad 2(N)6. Natml Eczema Swety meets the definibon of a public benefit entity under FRS 102. Assets and liabilits are inibalty recx)gnised at historical cy)sl or transaction value unless othemise stsled in the relevant 8¢(untr"ng px)licy. The financial slatements are prepared in steding whith is the functional and presentation81 ujrrenty of the Group and are rcHJnded to the nearest pound. The Consolidated Statement of Financial Activities (SOFA) and Consolidatsd Balance Sheet consolidate the financial statements of Ihe Charity and its subsidiary undertaking. The results of the subsidiary are consolided on a line ty line ba$. 2.2 Going concern The Trustees have assessed the use of ux)vJ ¢orKem and have considered pOSsle events or conditions that mvjht cast swJnficant doubl on the abiltty of the Group to continue as a going ¢oncem. The Trustees have made this assessment for a perK)d of at least one year from the date of the approval of these finanual ststements. The Trustees have conduded that there is a reasonable èxpectation that the GrcHJp has adequate resources to continue in operational existence for thè foreseeable frjture. and that no material un(rtainties exisL The Group theiefore continues lo adopt thg goiThJ nCeM basis in preparing th8se finan(ial ststements. Page21
NATIONAL ECZEMA SOCIETY (A Company Limit•d by Guaranteè) NOTES TO THE FINANCIAL STATEMEPITS FOR THE YEAR ENDED 31 DECEMBER 2021 counting policies (continued) 2.3 Income All irrne is recognised once Ihe Group has enlillemenl to the ineljme. it is probable that Ihe incom8 11 be received and the amount of income receivable can be measured rellay. For donations and gift aKI to be recognised the Group ryI1 have been notified of the amounts and the setUeTnenl dale in wrbting. If there are Cond"0n$ attsched to the donath?n and this requires a level of performance before entitlement can be obtained then income is defeThed until those conditions a Jlly met or the fvlfilment of those o)nditions is 7Mthin the control of the Group and it is probable that they will be fulfdled. The recognition of income from legacies is dependent on eStatlshIng entillemenl. the probability of receipt and the ability to estimate with sufficient ac(xJracy the amount receivable. Eviderice of entlement lo a acY exists when the Group has sufficient ewdence that a gift has been left lo them (through knowledge of the existence of a valid will and the death of the benelactorl and the executor is satisfied that the property in quest#)n wll nol be required to Satisfy claims in the estale. Receipt of a legacy must be regnIsed vthen it is Probab Ihat it will be received and the fair value of the amount receNabte. vthich wdl generaNy be the expecled cash amount lo be distribuled to the Grwp, Can be reliably measurerj. Substription income is received in full and reCOgrSed eventy over the course of the subwiplion. The 8mount re¢ognised in the Cortsdidated Ststemenl of Finanrial Activities relates to the financi81 peri&J in question. Income from trading acts"vities indudes incorne eamed from furKlraising even15 and trading activities to raise funds for the Group. Income is receNed in exchange for supplying goods and services in order to raise funds and is recognised when entiuement has occurred. 2.4 Expendlturo l expenditure is acccMJnled for on an a¢cnBls basis and has beon dassified urnjer headings Ihat aggregate all costs related lo the categories. EXperlture 15 rec(vJnised once there is a legal or nstruclive obligation to transfer ewiomic benefit lo a third party, il is probable that a transfer of ecorbomic benefits will be required in setuemenl and the amount of the oblat)n can be measured rellay. Exper)dItU is dassffied by activity. The costs of each activity are made up of the total of direct costs and shad costs. induding support cosls invow in undertaknng each activity. Direcl costs atth"butsble to a single aebvrty are alk)cated directly lo that activty. Shared costs which nlribule to more than one acttvity and supwrt costs which are not attributable to a single activity are apportior1 bets¥een those acts"vities on 8 basis ujnsistent with the use of re50urcs. Central staff costs are allocated on the tAsis of time spent. and depreciation charg8s allocated on the portion of the asset's use. Expenditure on charitsble activities ts Incurred on dweclly undertaklng the activities which fumher the Group's o'ectives. as well as any a$ated support $ts. All expenditure is inclUve of Irrecoverab VAT. Page 22
MATIONAL ECZEMA SOCIErf {A Company Limited by Guarant•e) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 A¢¢ounting poli¢ies {¢ontinued) 2.S Interèst r•celvable Interest on funds hekj on depos(( is Induded receivable and the amc4Jnt can be measured reliably by the Group: this is normally UFth notification of the interest pamj or payable by the inslilulion th whom the funds are d8F*)5ibJ. 2.6 Taxation The Charity is considered to pass the tests set out n Paragraph 1 SchethJle 6 of the Finance Act 2010 and thefOre it meets the definition of a charitatAe company for UK cOrporatn tax purposes. Accordingly. Ihe Charity is potentsally exempl from laxat40n in sPeCt of income or capital g81ns received Mlhin categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Ad 1992, to the exlent that such income or gains are apled exdusively lo charitsble PLrrrx)ses. 2.7 Intsnglbfe assets and amortlsatlon Inlaryible assets costing £500 or mrxe a ¢apitsh'sed arKI recognised when futu economlc benefits afe probable and the cosl or value of the asset can be measured reliably. Inlangible assets a inilialty recognised at C4)sl. After CJnIknOn. under the cost model. intsnglble assets are measured al wst less any accumulated am0rtjsat9n and any accumulated impairment losses. Amortisation is provided on intangible assets al rates cakulated lo te off the cost of each asset c a straighl-line basis over 3 years. Assets under construction are Th)t arThytised until ready for use. 2.8 Tanglble fixed assets and depreciation Tangible fixed assets costin9 £500 or more are caprtalised and reccgnised when future econ¢xnic benefits are probatAe and the cost or value of the asset can be measured reliably. Tangle fixed assets are initsally recognised at cost. After recognition. under the cost mrxlel. tsngible fixed assets are rneasU at cost less accJJmulated depreciation and any accumulated impairmenl losses. All costs inwrred to bring a tsngible ffixed asset into its intended wthing condilK)n should be induded in the measurement of cosL Al each rertIng dale the GrcAJp assesses Ythelher theo is any indication of irnpaimienl. If such indication exists, the recoverable amtsJnl of the asset i% determined to be the hBJher of its fair value less costs to sell and its value use. An impaiwt loss 1$ r)gnised Wre the canying amount exdS the recoverable amounL Page 23
NATIONAL ECZEMA SOCIETY IA Company Umlted by Guarant¢e} NOTES TO THE FINANCIAL STATEMEpirs FOR THE YEAR ENDED 31 DECEMBER 2021 A¢¢ounting policies (continued) 2.8 Twlble fixed assets and depreclatkn Icontlnued) Depreaation is tharged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, using the 5traighl-line melhomj. Depreoation is provided on the bases.. Leasehold improvements Fumiture and fittings offi equipment Computer equipment - over 10 years - over 10 years - over 10 years - over 3 years 1.9 Investments The invesknenl in the SLthidiary o)mpany 15 ¥aed at C05t less provision for impairrrMt. 2.10 Debtors Trade and other debt(X5 are recwni5ed al the setuement amount after any trade discount offered. Prepayrnents are vafued al Ihe amount (Kepaid net ol any trade discc¥Jnts due. 2.11 Cash at bank and in hand Cash at bank and in harKI includes cash arml short4erm hNJNy liquid invesb))ents with a short maturity of three months or less from the date of aC4siOn or opening of the deposit or similar accounl. 2.12 Llabllltles and provtslons Liabililies are renised lthen Ilwe 1$ an oNigatKJn at the Bala)ce Sheet dale as 8 result of a past evenl. it is pfobable that a transfer of ecorKXniC benefit ryI1 be required in settlemenl and the amount of the setuement (n be estimate(I reliably. Liabilities are recognised at ihe amount that the Group anlicipates it VAII pay lo settle the debt oi the amount rt has received as advanced payments for the goods or SeiceS it must provide. Proms$ are measured at the best estimate of the amounts quired to settle the obligats'on. Where the effect of the tsme value of money is materi81, the provision is based on the present value of Ihose amounls, dKscounted at the pre4ax disUnt rate that reflects the risks specific lo Ihe liability. The unwinding of the discounl is recognised in the ConsolKJated Stslement of Finanual Activities as a finance cost. Pag8 24
NATIONAL ECZEMA SOCIETY IA Company Umlled by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Accounllng poll¢les {¢ontSnuod) 2.13 Flnanclal Instruments The Grc4Jp only IkIS basic FlnancFal Instruments. The financial assets and financial liabilities of the Group are as ftAIows: Debtors other debtors are basic financial instruments aTrJ arg debt instrunIS msUre at amortised cost as detailed in Note 17. C8sh al bank- is classifie(l as a basic financial instrument and is meaSUd al face value. Liabilities- accruals are c4assffied as fThnc481 instNmenls. and are measured al amortised cost as detailed in Note5 18 arKI 19. 2.14 Operating leases RenL4s paid urKler ijperating leases are charged to the Consolidabj Statement of Financlal Activities on a strabJht line basis over the lease lenn. 2.15 Pensions The GrP is part of the Serie$ 3 Grcmth Plan whith 15 a Mulb*MoYer pensKJn Scheme which dosed in 2013. The Scheme administrators have confirmed that it is not possible lo separately identify the assets and liabilities of participating employers on a cLJnsislent and reasonable basis. The assets of the Scheme are CO&mingled for inveslment purposes and benefits are paid from lotal Scheme assets. A deficit reduclion plan has been agreed. The Group accounts for ils parbcipation in this Plan as a defined contribution plan. as there is insuffiuent inf0Mtion available to account for this as a defined bgnefrt plan. as Ihe share of its assets and liabilities cannot be identified. To avoid Cr111rY an immediate paymenl of Ihe aFparent under-fvndry in the Series 3 Stheme, the Group is paTts"¢ipab"ng in the Series 3 ReVery Plan and the liability is induded in Notes 17 and 18. The Grcyjp recognises ils liatslty to make payments to fvnd the deficit relating to past service under an agreement to make those paents. 11 rewgnises the full liability for the present value of contrilmrtions payable that SuIts from the agveemenl for fvnding the multi empl¢)yer plan. The Group also partiUP8les in a defined ¢tributiOn pension scheme for its employees. The Group pays fixed contribukn.ons into a separate scheme. Onee the defined contribution payments have been made, the GrcMJp has no further paent obligations in respect of this scheme. The C£Jnlributions are reo)gnised os an expense in the c$idated Statement of Financial ActivIe$ as they fall due. Page 25
NATIONAL ECZEMA SOCIETY (A Company Lirnited by Guarantw) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 OECEMBER 2021 Accounting policies Icontinu•d) 2.16 Fund accourrtlng General funds are unrestricled funds which are available for use al the discretion of the Trustees In furtherance of the general obJects"ve5 of the Group and which have not been designated for other purposes. DeSnated funds comprise unrestricted funds that have been set ashle by the Trustees for particular purposes. The aim and use of eath designated fvnd is set out in the notes to the fw)an¢ial slalements. Restricted fiKKls are fijnds are to be used in accordance speafic reslriclions imposed by donors or which have been raised by the Group for particJJlar purposes. The costs of raising and administering such fvnds are charged against the specfft fund. The aim and usa of èach festrKted fund is set out in the notes to the financial statements. Investrnenl rKome. gains and k)sses are alocated to approwiate fund. Critical accounting eslimate5 and areas of judgement Estimates and judgements are e4Jntinually eVaated arKI are based on historical experience and other factors. induding expectanS of future events Ihat are believed to be reasonable under the circUmstanS. Critical accounb'ng osts'mates aryl assumplions.. Thè Group mak8s estimates and assumptions o)nceming the frjtrxe. The resulling accounting estimates and assumptions will. by definiti. seldom equal the related actual resutts. The estimates and assumptK)ns that have a sKJnifKant risk of causing a material adjustrnent lo the carrying amounts of assets and liabilrties within the next finarKaal ar6 listsd beltr*. Allocation of support costs Depreciation rates for tsngible ffixed assets Useful econ¢>miC lives of assets The rate used in valuing the arnd Pensi(¥n Scheme defictt. The Board do not consider the Covid-19 pandemic to have had a material impact on these accounting estimates and areas of jLbdgemenL Page 26
NATIONAL ECZEMA SOCIETY IA Company Llmlted by Guarantee) NOTES TO THE FINANC STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Income from donatlons and legacles Unrestricted Restricted funds fund$ 2021 2021 Total funds 2021 Oonalions and similar income Legacies Subscriptions Gift aid 174,348 181,302 150,978 21.506 174.348 181.302 1SO,978 21.506 Total 2021 528.134 528.134 UnStriCte¢y funds 2020 Restricted funds 2020 Total fijnds 2020 Donations and similar ncome Lega(ies Subscryjtions Gift aid 143.976 199,306 149.389 24.406 28,810 172,786 199,306 149,389 24,406 Total 2020 517,077 28,810 545,887 Page 27
NATIONAL ECZEMA SOCIETY (A Company LSmlted by Guaranl•e) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Income from other trading a¢tivitses Income from fundralslng Unr•$tri¢ted funds 2021 Total funds 2021 Other cor)rate income Other actiwties 1.607 3.314 1,607 3,314 Total 2021 4,921 4,921 Unreslricted funds 2020 Total funds 2020 Other corporate income Other act711e5 587 734 587 734 Totsl 2020 1,321 1,321 In¢ome fr¢m trading activities Unre$tri¢ted funds 2021 Total funds 2021 Tra(Jing subsidiary 1.801 1.801 Unreslricled funds 2020 Total funds 2020 Trading subssdiary 1,809 Page 28
NATIONAL ECZEMA SOCIETY (A Company Urnlted by (knrantee) NOTES TO THE FINANCIAL STATEIAENTS FOR THE YEAR ENDED 31 DECEMBER 2021 In¢omo from Inve$tmonts Unr¢$lrl¢tad funds 2021 Total nds 2021 Bank intergsl receivatye 856 856 Unrestricted funds 2020 Total funds 2020 Bank interest receivable 2.143 2.143 Pa9e 29
NATIONAL ECZEMA SOCIETY (A Company Llmlted by Guarantee) NOTES TO THE FINANCIAL STATEME1s FOR THE YEAR ENDED 31 DECEMBER 2021 Expenditure on ralslng funds 2021 2020 Ftsndralsing ¢osts Direct csts Supwt Costs 27.431 5.373 28.685 26.005 32.804 54.690 Anatysis of support costs - fundraising Costs 2021 2020 Staff StS Depreciation Premises costs Carriage and postsge Professional fees Bought-in seNces Website, database and conw'ng Other costs Govgrnanco ¢0sts 7.390 663 779 3.388 174 560 30 $41 3.082 4.349 2.279 700 387 5,373 26.WS 2021 2020 Tradlng costs TIng subsidiary- Direct 1S In both the current arKI Previous financial stars all Expendith on raising funds was from ulestriCted funds. Page 30
NAMONAL ECZEMA SOCIETY (A Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Anatysis of expenditure on charitable activiti•s- by fund Unrestricted Restricted fund5 funds 2021 2021 Total funds 2021 Helpline Membership servi$ Infomiation $eN¢e$ 106.899 160.938 73.138 106,899 160.938 83.888 10.750 Total 2021 340.975 10.750 351,725 Unrestricted lund5 2020 Restricted funds 2020 Total lunds 2020 Helpline Membership services Infomation seryices 97,641 120,172 73.925 97,641 120,172 91,000 17.07S Total 2020 291.738 17,075 308,813 Page 31
NATIONAL ECZEMA SOCIETY (A Company Umlt•d by Guaranlee) NOTES TO THE ANANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Anatysis of expendIrn on charitabl• actl¥llies . by type Actlvltles undertaken directly 2021 Support costs 2021 Total funds 2021 Helpline Membership services Information services 64.245 85.626 44,631 42.654 75.312 39,257 106.899 160,938 83,888 Total 2021 194.502 157.223 351,725 undertaken dKeclly 2020 Support costs 2020 Total funds 2020 Helpline Membgrship servKes In1MatIon semces 46.835 57.125 43.257 97.641 120.172 91,¢XIO 63.047 47.743 Total 2020 161.596 147.217 308.813 Page 32
NATIONAL ECZEMA SOCIETY (A Company Llmlted by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Analysls of expenditure on charltatAe activities- by type (continued) Analysls of support costs Total funds 2021 Total funds 2020 Staff costs Depre¢iab'on Pr8mises $ts Carriagg and postsge Professional fees Bought-in services Website. database aNI compuling Othor ¢ost$ Governance costs 49.310 18,645 21.884 4,888 15,743 845 15.212 19.819 10,877 41.608 11.506 19.077 5,003 11.746 2.802 17.354 25.29) 12.831 157.223 147.217 10. Governance costs 2021 2020 Auditor5, reMural3n IrKlependent Examinerfs remuneration Rent & rates Insuran Trustees expenses Legal & professional fees Gener81 office expenses 9.000 5.505 {670} 6.386 (6021 6.151 30 27 11.264 15,110 Total Govemance costs atove comprise £387 (2020 - £2.2T9) of Expenditure on raising funds and £10.877 (2020- £12,831) of Expenditure on Charitable adMtie$. Page 33
NATIONAL ECZEMA SOCIE (A Company Llmlted by Guaranle•) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 11. Auditors. and Independent examinerfs remuneration 2021 2020 Audrts, remration- AL#Jil of the Gro and the TradirKJ Subsidiary Auditors. remuneTalion- Preparalxffi of Ihe ststsjtw accounts for the Group and the Trading Subsidiary Independent Examinerfs remuneration- Examinlion ofthe financial statements 9.540 2,100 5.505 12. Staff Costs Group 2021 Group 2020 Charity 2021 Charity 2020 Wages and salaries Social securily costs Pension costs 159.739 13.067 6.857 154.610 12.728 7.010 159,739 13.067 6.857 154.610 12,728 7,010 179,663 174.348 179.663 174,348 The average number of persons employed by tr Group duriry the >tar was as fdllyws: Group 2021 No. Grtsjp 2020 No. Direct charitatAe activitie5 Fundraising and communicat Support and govemance The nlber of ernpl0es wl)se em0 beneffts received (eXlIng employer pension costs) exceeded £60.(KJO was.. Group 2021 Group 2020 In the band £60.CK11- £70.0) The totsl amount of employee benefits. induding employers national insurance and pension contributions. ce[ve by Key Management Personnel is £72.305 (2020 £72,330). The Charity eonsiders its Key Management Personnel comprise the Trustees and the Chief Executive Officer. Page 34
NATIONAL ECZEMA SOCIETY (A Company Llmleed by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 13. Trustees. remuneralion and exn$¢$ DIng the lear, no Tnjstees recwed any wnuneration or other beneffts12020 - £NIL). OuTing thè ded 31 December 2021, No expenses were reimbursed or paid direcily to any Trustee 12020- £30 to 2 Trustees). 14. Intanglble a$sets Group and Charlty Website Cost At 1 January 2021 20,988 At 31 December 2021 20.988 Amortisation At 1 J3nuary2021 Charge for the ar 5.160 996 At 310ecember 2021 12.156 N•t book value At 31 December 2021 8.832 At 31 December 2020 15.828 Page 35
NATIONAL ECZEMA SOCIETY IA Company LImIl by Guarantsel NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 15. Tangible fix as$ots Group and Charlty Leasehold Fumlturn Improvements and fixtures Office Computer equipment equlpment Total Cost or valuation At 1 January2021 Additions 41.470 2.493 3.873 22.IM3 2,146 69.879 2,146 At 31 December 2021 41.470 2,493 3.873 24,189 72,025 Depreciation At 1 January 2021 Charge for the year 21.784 4.147 1N30 249 1.950 6,663 7,528 31,827 12,312 Al 31 Derntser 2021 25.931 1.679 2.338 14.191 44,139 Net b(¥ok value At 31 De¢ember 2021 1S539 814 1.535 27,886 At 31 Dember 2020 19.686 1.063 1.923 15.380 38,052 Page 36
NATIONAL ECZEMA SOCIErY (A Company Llmlted by Guarants•l NOTES TO THE FINANCIAL STATEMENTS FOR ThE YEAR ENDED 31 OECEMBER 2021 16. Fixèd asset inve$tfflents Investment $ub$idi*ry company Charity Cost oi valuation At 1 January 2021 100 At 31 De¢ember 2021 100 Page 37
NAnONAL ECZEMAsocErY NOTES TOTrIE FIIIANCIALSTATE¥EIITS FOR THE YEAR ENDED 31 0E¢EMBER2ts21 l& Flx•d IrN••lmqThts Prfn¢lpal •ubsldl(e Ilomè ComllY Règl$tev4d•ffle• c Hobthny number prfncfjpal plDc• ol bu$in•sS Ineluded In ¢onsolldatlon EczernaTrèJw¥J Lwnknd 1(Kl% Yes reyJR501thegknidwyfOrthèxVe'. N•t 116ti Ec1 TraLlw knrnited (5.QDQI P.1991 12N53 tKI rew¥B anltOriVrQrth 31 Jll1. rnembershp rnaga21ne is XCQLhltedfor in Eczema Tradiry Lyr. The S(Mxtykwps ihal rrAJhtconrtute Ir*liw ¥fxl 80
NATIONAL ECZEMA SOCIETY (A Company Limlted by Guaranteel NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDEO 31 DECEMBER 2021 17. Debtors Group 2021 GrcNJp 2020 Charity 2021 Charity 2020 Due within one year Trade debtors Amounts owed by group uThYertakirKJS Other debtors Prepayments and accrued inttKne 24.500 30.840 24.500 51.557 124.611 10.404 30,840 45.837 48.047 11.711 124.611 10A04 48.047 11.711 159.515 .598 211.072 136.435 18. Creditors: Amounts falling due tlthln one year Group 2021 Group 2020 Charlty 2021 Charity 2020 Trade creditors Other taxation and s101 security Other ¢reditors Accruals and deferred income 4.821 12.761 7,770 89.676 6.004 12.571 15.490 121.936 4,821 12,761 7.770 87.876 6.004 12.571 15.490 121,936 115.028 156,001 113.228 156,001 Group 2021 Group 2020 Charity 2021 Charity 2020 Deferred Income Deferred income at 1 January Resources deferred during the year Amounts rdea5ed from previous pwKKIs 103.016 75.422 (103.016) 85,119 103.016 103.016 73.622 185.119) 1103.016) 83,319 103,016 183,3191 O¢ferred In¢¢)me at 31 DMr 75.422 103.016 73,622 103,016 Deferred income consists of membership income relating to future perio(ts. Page 39
NATIONAL ECZEMA SOCIETY (A Company Llmlt¢d by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 19. Credltors: Amounts falllng due after more than one year Group 2021 Group 2020 Charity 2021 Charity 2020 Pension Scheme deficil 8,T14 49.863 8.T14 49.863 The Charity is paitipating in a recovery an to eliminate its Series 3 scheme deficit over a ten year period. The Pensions Trust. the scheme administralor. has however adwsed that the amount of employer debt on the altemative of wthdrawal from the Series 3 scheme has been estimated by actuaries to have been £200,161 as al 31 December 2016. As the Charity intends to conlinue partiupating in the recovery plan, no proviwon has been made for this polenllal withdrawal debl however. the sIety aUnted for the present value of all remaining o)ntributions urvjer the recovery an in the 2017 accounts al their present value of £120.¢)00. as advised by the scheme Jministrator. This liabilty has been adjusted annually to unwnd the rdevant discount applted. In order lo meet their share of the shortfall. the Charity ha5 been asked to pay addtlional contributions lo scheme until 2025. A full actuarial valuation was carried CArt by the actuaries at 30 September 2017 and the funding shortfall ol¢ulated al that date gave rise to a remeasurement reduCtN of £15.624 in the deficrt as at 31 December 2018. The deficit of the scheme is £15.879 (2020 - £65. 796) 8131 December 2021. The payment by the Charrty in the year was £15.333 {2020 - £14.887) with an Inte$t payment of £155 (2020- £794) and a remeasurement expense of {£180} (2020- £1.121). In addits"on, the Charity elected to swrtch. effect from 1 October 2013. from Series 3 to Series 4, defined contribution s¢heme. The pension Cost in the accounts represents amounts payable by the Charity as ordinary employer contrityJlions to the Series 4 defingd nIributiOn frJnd. During Ihe yEar ernOyer contributions of £6.858 (2020- £7.010). interest of £155 (2020- £794). actuarial Igains)llosses of (£180) (2020 - £7.121) and remeasurements for amendments to the (a)ntribution hedule of 1£33.9591 (2020 - £NIL) have ten charged to the Consolidated Statement of Financial ActNilies. There were rn accrued conlritrNJtions al 31 0e(tmber 2021 12020 - £NIL) but there is a liability of £15.879 (2020 - £65. 196) for future contributs.ons under the Series 3 Recovery Plan. Of this £7,105 (2020 - £15,333) is reed in Creditors: Amounts falling due within cme year as part of Other Creditors and £8,774 {2020- £49,863) 15 reported in Credrkms.. Amounts falling due after more then one year. Page 40
NATIONAL ECZEMA SOCIETY {A Company Llmlted by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 20. Statement of funds Statoment of funds - current year Balan¢• at 31 Galnsl December {L05se5} 2021 Balance at 1 January 2021 Trnnsfefs Inlout Income Expendlture Unre$tri¢ted fund5 Designated funds Fixed asset fund Pension reserve {19,308) 1155) 2.146 15.333 36,718 (15.8791 165,196) 34.139 119.463) 17.479 34.139 20.839 Gonoral fvnd$ General funds 535,197 535.712 1354.316 (17.479) 699.114 Tol•l Unrestricted funds 523.881 535,712 (373,779 34.139 719.953 Restri¢ttd fund5 Research 12.488 {10.7501 1.738 Total of funds 536.369 535.712 (384.529) 34,139 721.691 Page 41
NATIONAL ECZE SOCIETY IA Company Llmlted by Guaranlee) NOTES TO THE FINANCIAL STATEIAENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Slatement of funds (continued St•tement ot funds- prior y•ar Balance al 31 December 2020 Balanc8 at 1 January 2020 Transfets lout Gainsl (Losses) Income ExperKlilure Unrestricted funds Designated fvnds Fixed asset fund Pension reserve 44.072 (78.168) (13.SS)) (794) 23.3S8 14.887 53.880 {65.1961 (1.121) (34.0961 (14.344) 38.245 (1.1211 {11,3161 G¢neTal lunds General funds 383,191 522.350 1332,(199) {38,245) 535,197 Total Unr•strl¢ted funds 349.095 522.350 1346.443) (1.121) 523,881 Restricted funds Research ThankQ Laptops 753 11,735 13,8(M) 3.275 12.488 (13.8CM)) (3.275) 753 28.810 117.075) 12.488 Total of funds 349.848 551.160 {363.518) 11.121) 536.369 Page 42
NATIONAL ECZEMA SOCIEtY (A Company Llmlt•d by Guarantee NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 OECEMBER 2021 20. Statement of funds (conlinu•d) Desl nat•d funds The Penslon reserye has been established to shtyv future pensh)n def1t payments In regards lo defined benefit pensKin stheme. Thbs pension scheme is beiNJ treated as a defined contribution pension scheme as a rellae estimate cannot be made of the liability at the year end. The transfer of £15,333 was made to separate the deftcil payments due as al 31 December 2021 from the Unrestricted general lund. Actuarial gains I Ilossesl are charged to thi5 fur as they arise. The Fixed asset fvnd has been esta1Shed to rellect the furKls tied up in Tangible and Intaryjible fixed assets and agrees bath to the Net Book Value presented on the Consolidated Balance Sheel. The transfer of £2.146 was made to represent capital additsons during the year. Depreciation is charged to this fund as expenditure. Unrestricted fvnds General lurKls refiects funds which ar8 available for use at the discretion of the Trustees in furtherance of the general objectives of Ihe Charity and vthich have not been designated for 0lh8r purposes. strlcted fund$ The Rese*th fund exists to provide SoUrceS for research into the causes of Eczema. wrih the aim of ¢Jevelopin9 MO effeclive treatrnents or a Cure. The Society is gratefvl lo corporate members. Abbvie and Sanoffi. whth provided restricted funding to upgrade Ihe Socie$ supporter database sofhyare. ThankQ. and implement cloud-based hosting. This work was essential in supporling more efficient MOte wothing by the staff team, whith was needed in response lo the Covi&19 pandemic. The Swety is grateful to the British Association of Dermatologists who provided fundirrfJ for the $Ofva licence and Trting fe8$ for the first year ol use of the Societls upjraded supporter datase. The Society 15 gratef lo the company Amirall, which prov¢ded restn.cted fijnding for new laptop computers and related costs. needed to faulitate IK)me by the staff team in response to the Covid-19 pandemic. Page 43
NATIONAL ECZEMA SOCIETY (A Company Umlted by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 21. Anaty$ls of net assets between funds Anatysls of not assets b8twoen funds - wrvent year Unr•$trld•d R•strlcted fund$ fvnds 2021 2021 Total funds 2021 Tangible fixed assels lntsn9ie fixed assets Current assets Creditors due within one year creth.lors due in MO than one )ear 27.886 8.832 807.037 (115,0281 {8,774) 27.886 8.832 808.775 (11S.0281 18.7741 1,738 Total 719,953 1,738 721.691 Anatysls of not ossets b•twn fvnds- prlor y•ar Ur¥estricted Restrided fvnds fvnds 2020 2020 Totsl fund5 2020 Tangible fixed assets Intangible fixed assets Current assets cditOrS due within one ar Cro¢thtors due in more than one year 38,052 15.828 675.865 (156.001) 149.863) 38.052 15,828 688,353 (156,001 } 149,863) 12.488 Totsl 523.881 12.488 536,369 Page 44
NATIONAL ECZEMA SOCIETY IA Company Llmlt¢d by Guarnntee} NOTES TO THE FINANCIAL STATEMEKrs FOR THE YEAR ENDED 31 DECEMBER 2021 22. Reconclliatlon of net movement in funds to net cash ftow from operntlng actlvltles GTOUP 2021 Gro 2020 Nel income for the year (as ppr Statement of F181 Ac*vthsl 151,183 187,642 Adju$tments for: Depreciation charges AMorlisa0n charges Investment income 15 14 12.312 6.996 1856) (114.754) 12.086) 8,390 5,160 {2,1431 (26,9501 7,940 InL¥ease in debtors {DerxeaseYincrease in ¢ditorS 17 18 Net cash provldtd by operating aclivitles 52.795 180,039 23. Anatysls of cash and &ish equlvalents Group 2021 Group 2020 Cash in hand 649.260 597.755 Total cash and cash equivalents 649.260 597.755 24. Analysls of Changes In net dèbt At31 De¢ember 2021 January 2021 Cash flows Cash at bank and in harKI 597.755 51.SOS 649.260 597.755 51.505 649.260 Page 45
NATIONAL ECZEMA SOCIETY IA Company Llmited by Guarant••) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 25. Operaling kase ¢ommltments At 31 Decembw 2021 thè GrLp and the Charity h&J commitments to make future minimum lease pwnents under ThJnwcancellat4e operating lease$ as foll¢$". Group 2021 Group 2020 Charity 2021 Charity 2020 Not later than 1 year Later than 1 year arKI not later than 5 sea 21,000 46,333 20.833 66.500 21,000 46,333 20.833 66,5(K) 67.333 87.333 67,333 87.333 The followng lease paents have been recogni5ed as an expertse in the Consolidated Stslemenl of Financial Activities.. Group 2021 Grwp 2020 eharlty 2021 Charity 2020 Operating lease rentals 20,833 20.000 20,833 20,Cw)O 26. Related party transactlons In the year ended 31 L)ecember 2021, donations of £1.200 (2020- £NILJ were made by 1 Trustee (2020- None) lo the Charity. Page 46